Erratum Regarding “Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial” (American Journal of Kidney Diseases (2018) 71(1) (65–74), (S0272638617308934), (10.1053/j.ajkd.2017.07.015));Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial

American Journal of Kidney Diseases

Volumn 71, Issue 1, 2018, Pages 65-74

  Bjornstad, Petter ^a   Nehus, Edward ^b   El ghormli, Laure ^c   Bacha, Fida ^d   Libman, Ingrid M ^e   McKay, Siripoom ^d   Willi, S ^h   Laffel, Lori ^g,h   Arslanian, S ^h   Nadeau, Kristen J ^a   McKay, S ^h   Haymond, M ^h   Anderson, B ^h   Bush, C ^h   Gunn, S ^h   Holden, H ^h   Jones, S M ^h   Jeha, G ^h   McGirk, S ^h   Thamotharan, S ^h   Cuttler, L ^h   Abrams, E ^h   Casey, T ^h   Dahms, W ^h   Ievers Landis, C ^h   Kaminski, B ^h   Koontz, M ^h   MacLeish, S ^h   McGuigan, P ^h   Narasimhan, S ^h   Geffner, M ^h   Barraza, V ^h   Chang, N ^h   Conrad, B ^h   Dreimane, D ^h   Estrada, S ^h   Fisher, L ^h   Fleury Milfort, E ^h   Hernandez, S ^h   Hollen, B ^h   Kaufman, F ^h   Law, E ^h   Mansilla, V ^h   Miller, D ^h   Munoz C ^h   Ortiz, R ^h   Ward, A ^h   Wexler, K ^h   Xu, Y K ^h   Yasuda, P ^h   Levitt Katz, L ^h   Berkowitz, R ^h   Boyd, S ^h   Johnson, B ^h   Kaplan, J ^h   Keating, C ^h   Lassiter, C ^h   Lipman, T ^h   McGinley, G ^h   McKnight, H ^h   Schwartzman, B ^h   Bacha, F ^h   Foster, S ^h   Galvin, B ^h   Hannon, T ^h   Kriska, A ^h   Libman, I ^h   Marcus, M ^h   Porter, K ^h   Songer, T ^h   Venditti, E ^h   Goland, R ^h   Gallagher, D ^h   Kringas, P ^h   Leibel, N ^h   Ng, D ^h   Ovalles, M ^h   Seidman, D ^h   Goebel Fabbri, A ^h   Hall, M ^h   Higgins, L ^h   Keady, J ^h   Malloy, M ^h   Milaszewski, K ^h   Rasbach, L ^h   Nathan, D M ^h   Angelescu, A ^h   Bissett, L ^h   Ciccarelli, C ^h   Delahanty, L ^h   Goldman, V ^h   Hardy, O ^h   Larkin, M ^h   Levitsky, L ^h   McEachern, R ^h   Norman, D ^h   Nwosu, D ^h   Park Bennett, S ^h   Richards, D ^h   Sherry, N ^h   Steiner, B ^h   Tollefsen, S ^h   Carnes, S ^h   Dempsher, D ^h   Flomo, D ^h   Whelan, T ^h   Wolff, B ^h   Weinstock, R ^h   Bowerman, D ^h   Bristol, S ^h   Bulger, J ^h   Hartsig, J ^h   Izquierdo, R ^h   Kearns, J ^h   Saletsky, R ^h   Trief, P ^h   Zeitler, P ^h   Abramson, N ^h   Bradhurst, A ^h   Celona Jacobs, N ^h   Higgins, J ^h   Kelsey, M ^h   Klingensmith, G ^h   Nadeau, K ^h   Witten, T ^h   Copeland, K ^h   Boss, E ^h   Brown, R ^h   Chadwick, J ^h   Chalmers, L ^h   Chernausek, S ^h   Hebensperger, A ^h   Macha, C ^h   Newgent, R ^h   Nordyke, A ^h   Olson, D ^h   Poulsen, T ^h   Pratt, L ^h   Preske, J ^h   Schanuel, J ^h   Sternlof, S ^h   Lynch, J ^h   Amodei, N ^h   Barajas, R ^h   Cody, C ^h   Hale, D ^h   Hernandez, J ^h   Ibarra, C ^h   Morales, E ^h   Rivera, S ^h   Rupert, G ^h   Wauters, A ^h   White, N ^h   Arbelaez A ^h   Jones, J ^h   Jones, T ^h   Sadler, M ^h   Tanner, M ^h   Timpson, A ^h   Welch, R ^h   Caprio, S ^h   Grey, M ^h   Guandalini, C ^h   Lavietes, S ^h   Rose, P ^h   Syme, A ^h   Tamborlane, W ^h   Hirst, K ^h   Edelstein, S ^h   Feit, P ^h   Grover, N ^h   Long, C ^h   Pyle, L ^h   Linder, B ^h   Marcovina, S M ^h   Harting, J ^h   Shepherd, J ^h   Fan, B ^h   Marquez, L ^h   Sherman, M ^h   Wang, J ^h   Nichols, M ^h   Mayer Davis, E ^h   Liu, Y ^h   Lima, J ^h   Gidding, S ^h   Puccella, J ^h   Ricketts, E ^h   Danis, R ^h   Domalpally, A ^h   Goulding, A ^h   Neill, S ^h   Vargo, P ^h   Wilfley, D ^h   Aldrich Rasche, D ^h   Franklin, K ^h   Massmann, C ^h   O'Brien, D ^h   Patterson, J ^h   Tibbs, T ^h   Van Buren, D ^h   Palmert, M ^h   Ratner, R ^h   Dremaine, D ^h   Silverstein, J ^h   more..

^a UNIVERSITY OF COLORADO   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g JOSLIN DIABETES CENTER   (United States)

^h Joslin Diabetes Center ^*

Author keywords

adolescents; albumin creatinine ratio (ACR); children; creatinine; cystatin C; diabetic kidney disease (DKD); disease progression; estimated glomerular filtration rate (eGFR); hyperfiltration; increased albumin excretion; insulin sensitivity; kidney function; Type 2 diabetes mellitus (T2DM); youth onset T2DM

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHILD; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; DRUG EFFICACY; ESTIMATED GLOMERULAR FILTRATION RATE; ETHNICITY; FEMALE; GLOMERULUS FILTRATION; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INCIDENCE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; BLOOD; CLINICAL TRIAL; COMPLICATION; DISEASE EXACERBATION; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; MORBIDITY; MULTICENTER STUDY; NUTRITION; PHYSIOLOGY; SURVIVAL RATE; TIME FACTOR; TRENDS; UNITED STATES;

ADOLESCENT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLYCATED HEMOGLOBIN A; HUMANS; INSULIN RESISTANCE; MORBIDITY; NUTRITION SURVEYS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 85034050494     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2019.02.001     Document Type: Erratum

References (45)

1. Collins, A.J., Foley, R.N., Herzog, C., et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis, 57(1 suppl 1), 2011, A8 e1-e526.
2. Bjornstad, P., Maahs, D.M., Cherney, D.Z., et al. Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes. Diabetes Care 37:11 (2014), 3033–3039.
3. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36:6 (2013), 1735–1741.
4. Alleyn, C.R., Volkening, L.K., Wolfson, J., Rodriguez-Ventura, A., Wood, J.R., Laffel, L.M., Occurrence of microalbuminuria in young people with type 1 diabetes: importance of age and diabetes duration. Diabet Med 27:5 (2010), 532–537.
5. Eppens, M.C., Craig, M.E., Cusumano, J., et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29:6 (2006), 1300–1306.
6. Kiess, W., Bottner, A., Bluher, S., Raile, K., Galler, A., Kapellen, T.M., Type 2 diabetes mellitus in children and adolescents—the beginning of a renal catastrophe?. Nephrol Dial Transplant 19:11 (2004), 2693–2696.
7. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22:1 (1999), 99–111.
8. Yokoyama, H., Okudaira, M., Otani, T., et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 20:5 (1997), 844–847.
9. Yokoyama, H., Okudaira, M., Otani, T., et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis. Diabetes Care 21:7 (1998), 1080–1085.
10. Rodriguez, B.L., Dabelea, D., Liese, A.D., et al. Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for Diabetes in Youth Study. J Pediatr 157:2 (2010), 245–251.e1.
11. Drummond, K., Mauer, M., The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51:5 (2002), 1580–1587.
12. Bjornstad, P., Cherney, D.Z., Maahs, D.M., Nadeau, K.J., Diabetic kidney disease in adolescents with type 2 diabetes: new insights and potential therapies. Curr Diabetes Rep 16:2 (2016), 1–11.
13. Lytvyn, Y., Bjornstad, P., Pun, N., Cherney, D.Z., New and old agents in the management of diabetic nephropathy. Curr Opin Nephrol Hypertens 25:3 (2016), 232–239.
14. Retnakaran, R., Cull, C.A., Thorne, K.I., Adler, A.I., Holman, R.R., Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55:6 (2006), 1832–1839.
15. Chen, J., Muntner, P., Hamm, L.L., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14:2 (2003), 469–477.
16. Li, H., Satriano, J., Thomas, J.L., et al. Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease. Am J Physiol Renal Physiol 309:5 (2015), F414–F428.
17. Miyamoto, S., Hsu, C.C., Hamm, G., et al. Mass spectrometry imaging reveals elevated glomerular ATP/AMP in diabetes/obesity and identifies sphingomyelin as a possible mediator. EBioMedicine 7 (2016), 121–134.
18. Schrier, R.W., Harris, D.C., Chan, L., Shapiro, J.I., Caramelo, C., Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am J Kidney Dis 12:3 (1988), 243–249.
19. Mottl, A.K., Divers, J., Dabelea, D., et al. The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type. Pediatr Nephrol 31:6 (2016), 933–940.
20. Prigent, A., Monitoring renal function and limitations of renal function tests. Semin Nucl Med 38:1 (2008), 32–46.
21. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366:24 (2012), 2247–2256.
22. Zeitler, P., Epstein, L., Grey, M., et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 8:2 (2007), 74–87.
23. Bacha, F., Pyle, L., Nadeau, K., et al. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes 13:5 (2012), 376–383.
24. George, L., Bacha, F., Lee, S., Tfayli, H., Andreatta, E., Arslanian, S., Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab 96:7 (2011), 2136–2145.
25. Bacchetta, J., Cochat, P., Rognant, N., Ranchin, B., Hadj-Aissa, A., Dubourg, L., Which creatinine and cystatin C equations can be reliably used in children?. Clin J Am Soc Nephrol 6:3 (2011), 552–560.
26. Fadrowski, J.J., Neu, A.M., Schwartz, G.J., Furth, S.L., Pediatric GFR estimating equations applied to adolescents in the general population. Clin J Am Soc Nephrol 6:6 (2011), 1427–1435.
27. American Diabetes Association. 10. Microvascular complications and foot care. Diabetes Care 40:suppl 1 (2017), S88–S98.
28. Amin, R., Turner, C., van Aken, S., et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: the Oxford Regional Prospective Study. Kidney Int 68:4 (2005), 1740–1749.
29. Magee, G.M., Bilous, R.W., Cardwell, C.R., Hunter, S.J., Kee, F., Fogarty, D.G., Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:4 (2009), 691–697.
30. Remuzzi, G., Benigni, A., Remuzzi, A., Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116:2 (2006), 288–296.
31. Cherney, D.Z., Scholey, J.W., Miller, J.A., Insights into the regulation of renal hemodynamic function in diabetic mellitus. Curr Diabetes Rev 4:4 (2008), 280–290.
32. Dart, A.B., Sellers, E.A., Martens, P.J., Rigatto, C., Brownell, M.D., Dean, H.J., High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care 35:6 (2012), 1265–1271.
33. Hsu, C.C., Chang, H.Y., Huang, M.C., et al. Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study. Diabetes Care 34:4 (2011), 982–987.
34. Catalano, C., Muscelli, E., Quinones Galvan, A., et al. Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes 46:5 (1997), 868–875.
35. Cohen, A.J., McCarthy, D.M., Stoff, J.S., Direct hemodynamic effect of insulin in the isolated perfused kidney. Am J Physiol 257:4, pt 2 (1989), F580–F585.
36. Tucker, B.J., Anderson, C.M., Thies, R.S., Collins, R.C., Blantz, R.C., Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 42:5 (1992), 1160–1168.
37. Parvanova, A.I., Trevisan, R., Iliev, I.P., et al. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 55:5 (2006), 1456–1462.
38. De Cosmo, S., Minenna, A., Ludovico, O., et al. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association. Diabetes Care 28:4 (2005), 910–915.
39. Okada, R., Yasuda, Y., Tsushita, K., Wakai, K., Hamajima, N., Matsuo, S., Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 27:5 (2012), 1821–1825.
40. Yamada, T., Komatsu, M., Komiya, I., et al. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study. Diabetes Care 28:11 (2005), 2733–2738.
41. August, P., Hardison, R.M., Hage, F.G., et al. Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study. Clin J Am Soc Nephrol 9:1 (2014), 64–71.
42. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am Heart J 156:3 (2008), 528–536 36 e1-e5.
43. Muniyappa, R., Lee, S., Chen, H., Quon, M.J., Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294:1 (2008), E15–E26.
44. Burns, S.F., Bacha, F., Lee, S.J., Tfayli, H., Gungor, N., Arslanian, S.A., Declining beta-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care 34:9 (2011), 2033–2040.
45. Sharma, A.P., Yasin, A., Garg, A.X., Filler, G., Diagnostic accuracy of cystatin C-based eGFR equations at different GFR levels in children. Clin J Am Soc Nephrol 6:7 (2011), 1599–1608.